Substance / Medication

Cefpodoxime proxetil

Overview

Clinical overview including description, indications, and evidence base is pending physician authorship or FDA SPL integration. Graph-derived relationship data is available below.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Clinical Trials

37 trials linked to this intervention

37
Total Trials
7
Recruiting
10
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Cefpodoxime proxetil compared with cefixime for treatment of typhoid fever in children.
Shakur Md Salim, Arzuman Selina Akhter Laila, Hossain Jesmin et al. · Indian Pediatr · 2007
PMID: 18057480RCT
The comparative plasma pharmacokinetics of intravenous cefpodoxime sodium and oral cefpodoxime proxetil in beagle dogs.
Brown S A, Boucher J F, Hubbard V L et al. · J Vet Pharmacol Ther · 2007
PMID: 17610405RCT
Development and validation of HPLC method for the determination of Cefpodoxime Proxetil in human plasma.
Bashir Lubna, Shoaib Muhammad Harris, Naz Shazia et al. · Pak J Pharm Sci · 2017
PMID: 29084679Observational
Simultaneous quantification of cefpodoxime proxetil and clavulanic acid in human plasma by LC-MS using solid phase extraction with application to pharmacokinetic studies.
Dubala Anil, Nagarajan Janaki Sankarachari Krishnan, Vimal Chandran Sathish et al. · J Chromatogr B Analyt Technol Biomed Life Sci · 2013
PMID: 23434877Observational
Design and evaluation of self-nanoemulsifying drug delivery systems (SNEDDS) for cefpodoxime proxetil.
Date Abhijit A, Nagarsenker M S · Int J Pharm · 2007
PMID: 17010543Observational

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Cefpodoxime proxetil (substance)
SNOMED CT
96050003
UMLS CUI
C0108938

Clinical Data

This intervention maps to 20 entities in the Healos knowledge graph.

20
Conditions
0
Biomarkers
0
Specialists
0
Symptoms
37
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.